p28gst
Recombinant proteinexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02281916)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutathione S-transferaseSupplementation
GST supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- p28gst
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02281916 | Phase 2 | Mar 1, 2014 | Institut National de la Santé Et de la Recherche Médicale, France, National Research Agency, France, University of Lille |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | Academic/Hospital | 1 | 0 | 1 | 2014 |
| National Research Agency, France | Government | 1 | 0 | 1 | 2014 |
| University of Lille | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1